307 related articles for article (PubMed ID: 19383915)
1. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
Graff JR; Konicek BW; Lynch RL; Dumstorf CA; Dowless MS; McNulty AM; Parsons SH; Brail LH; Colligan BM; Koop JW; Hurst BM; Deddens JA; Neubauer BL; Stancato LF; Carter HW; Douglass LE; Carter JH
Cancer Res; 2009 May; 69(9):3866-73. PubMed ID: 19383915
[TBL] [Abstract][Full Text] [Related]
2. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
Salehi Z; Mashayekhi F
Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
[TBL] [Abstract][Full Text] [Related]
3. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
Hu J; Straub J; Xiao D; Singh SV; Yang HS; Sonenberg N; Vatsyayan J
Cancer Res; 2007 Apr; 67(8):3569-73. PubMed ID: 17440067
[TBL] [Abstract][Full Text] [Related]
4. Targeting the eukaryotic translation initiation factor 4E for cancer therapy.
Graff JR; Konicek BW; Carter JH; Marcusson EG
Cancer Res; 2008 Feb; 68(3):631-4. PubMed ID: 18245460
[TBL] [Abstract][Full Text] [Related]
5. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.
Andrieu C; Taieb D; Baylot V; Ettinger S; Soubeyran P; De-Thonel A; Nelson C; Garrido C; So A; Fazli L; Bladou F; Gleave M; Iovanna JL; Rocchi P
Oncogene; 2010 Apr; 29(13):1883-96. PubMed ID: 20101233
[TBL] [Abstract][Full Text] [Related]
7. Regulation of human eIF4E by 4E-BP1: binding analysis using surface plasmon resonance.
Youtani T; Tomoo K; Ishida T; Miyoshi H; Miura K
IUBMB Life; 2000 Jan; 49(1):27-31. PubMed ID: 10772338
[TBL] [Abstract][Full Text] [Related]
8. Effect of N-terminal region of eIF4E and Ser65-phosphorylation of 4E-BP1 on interaction between eIF4E and 4E-BP1 fragment peptide.
Tomoo K; Abiko F; Miyagawa H; Kitamura K; Ishida T
J Biochem; 2006 Aug; 140(2):237-46. PubMed ID: 16825247
[TBL] [Abstract][Full Text] [Related]
9. The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin.
Kjellerup RB; Iversen L; Kragballe K; Johansen C
Br J Dermatol; 2009 Nov; 161(5):1059-66. PubMed ID: 19663871
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.
Dubois L; Magagnin MG; Cleven AH; Weppler SA; Grenacher B; Landuyt W; Lieuwes N; Lambin P; Gorr TA; Koritzinsky M; Wouters BG
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1219-27. PubMed ID: 19251093
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy.
Benavente S; Vergés R; Hermosilla E; Fumanal V; Casanova N; García A; Ramón Y Cajal S; Giralt J
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1316-22. PubMed ID: 19362787
[TBL] [Abstract][Full Text] [Related]
12. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics.
Dai B; Kong YY; Ye DW; Ma CG; Zhou X; Yao XD
BJU Int; 2009 Oct; 104(7):1009-16. PubMed ID: 19389013
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1.
Tan A; Bitterman P; Sonenberg N; Peterson M; Polunovsky V
Oncogene; 2000 Mar; 19(11):1437-47. PubMed ID: 10723135
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel induces the phosphorylation of the eukaryotic translation initiation factor 4E-binding protein 1 through a Cdk1-dependent mechanism.
Greenberg VL; Zimmer SG
Oncogene; 2005 Jul; 24(30):4851-60. PubMed ID: 15897904
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma.
Seki N; Takasu T; Sawada S; Nakata M; Nishimura R; Segawa Y; Shibakuki R; Hanafusa T; Eguchi K
Lung Cancer; 2010 Dec; 70(3):329-34. PubMed ID: 20621385
[TBL] [Abstract][Full Text] [Related]
16. The embryonic pregnancy signal oestradiol influences gene expression at the level of translational initiation in porcine endometrial cells.
Wollenhaupt K; Brüssow KP; Tiemann U; Tomek W
Reprod Domest Anim; 2007 Apr; 42(2):167-75. PubMed ID: 17348974
[TBL] [Abstract][Full Text] [Related]
17. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer.
Narita S; So A; Ettinger S; Hayashi N; Muramaki M; Fazli L; Kim Y; Gleave ME
Clin Cancer Res; 2008 Sep; 14(18):5769-77. PubMed ID: 18794086
[TBL] [Abstract][Full Text] [Related]
18. Binding preference of eIF4E for 4E-binding protein isoform and function of eIF4E N-terminal flexible region for interaction, studied by SPR analysis.
Abiko F; Tomoo K; Mizuno A; Morino S; Imataka H; Ishida T
Biochem Biophys Res Commun; 2007 Apr; 355(3):667-72. PubMed ID: 17316564
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
[TBL] [Abstract][Full Text] [Related]
20. Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoter.
Yu D; Scott C; Jia WW; De Benedetti A; Williams BJ; Fazli L; Wen Y; Gleave M; Nelson C; Rennie PS
Cancer Gene Ther; 2006 Jan; 13(1):32-43. PubMed ID: 16052226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
